ask="19.50"
ask_size="300"
average_daily_volume="143323"
bid="N/A"
bid_size="N/A"
book_value="6.55"
change="-0.08"
change_from_200_day_moving_average="1.41"
change_from_50_day_moving_average="0.41"
change_from_52_week_high="-2.38"
change_From_52_week_low="5.10"
change_in_percent="-0.47%"
close="17.12"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.01"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.06"
ex_dividend_date="N/A"
float_shares="11581000"
high="17.39"
high_52_weeks="19.50"
last_trade_date="2/22/2017"
last_trade_price="17.12"
last_trade_size="2126"
last_trade_time="4:00pm"
low="17.03"
low_52_weeks="12.02"
market_capitalization="376.33M"
moving_average_200_day="15.71"
moving_average_50_day="16.71"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.83"
open="17.28"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+8.95%"
percent_change_from_50_day_moving_average="+2.48%"
percent_change_from_52_week_high="-12.21%"
percent_change_from_52_week_low="+42.43%"
previous_close="17.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.62"
price_per_sales="357.03"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="19.33"
stock_exchange="NGM"
symbol="ADMS"
volume="66890"
weeks_range_52="12.02 - 19.50"
